Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsAllogeneic, bone marrow-derived MSCs were systemically administered into patients with stable chronic obstructive pulmonary disease. Gene expression profiles from peripheral blood mononuclear cells were analyzed across the first week after infusion.
[Stem Cells Translational Medicine]
6445212 EFV462L9 items 1 apa 0 default asc 1 165928 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-f61be7358b100769f67e344c4fde5e44%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22EFV462L9%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Armitage%20et%20al.%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EArmitage%2C%20J.%20D.%2C%20Tan%2C%20D.%20B.%20A.%2C%20Sturm%2C%20M.%2C%20%26amp%3B%20Moodley%2C%20Y.%20P.%20%28n.d.%29.%20Transcriptional%20profiling%20of%20circulating%20mononuclear%20cells%20from%20patients%20with%20chronic%20obstructive%20pulmonary%20disease%20receiving%20mesenchymal%20stromal%20cell%20infusions.%20%3Ci%3ESTEM%20CELLS%20Translational%20Medicine%3C%5C%2Fi%3E%2C%20%3Ci%3En%5C%2Fa%3C%5C%2Fi%3E%28n%5C%2Fa%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fsctm.21-0024%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fsctm.21-0024%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DEFV462L9%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transcriptional%20profiling%20of%20circulating%20mononuclear%20cells%20from%20patients%20with%20chronic%20obstructive%20pulmonary%20disease%20receiving%20mesenchymal%20stromal%20cell%20infusions%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jesse%20D.%22%2C%22lastName%22%3A%22Armitage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dino%20B.%20A.%22%2C%22lastName%22%3A%22Tan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Sturm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuben%20P.%22%2C%22lastName%22%3A%22Moodley%22%7D%5D%2C%22abstractNote%22%3A%22Chronic%20obstructive%20pulmonary%20disease%20%28COPD%29%20is%20an%20inflammatory%20airways%20disease%20with%20limited%20therapeutic%20options.%20We%20have%20previously%20shown%20that%20mesenchymal%20stromal%20cell%20%28MSC%29%20infusions%20are%20well%20tolerated%20in%20patients%20with%20COPD%20and%20reduce%20circulatory%20biomarkers%20associated%20with%20systemic%20inflammation%20and%20oxidative%20stress.%20This%20study%20aimed%20to%20delineate%20the%20underlying%20mechanisms%20further%20by%20characterizing%20the%20transcriptional%20networks%20in%20these%20patients%20and%20to%20explore%20the%20role%20of%20MSC-derived%20paracrine%20factors%20in%20regulating%20these%20pathways.%20Allogeneic%2C%20bone%20marrow-derived%20MSCs%20were%20systemically%20administered%20into%20patients%20with%20stable%20COPD%20%28n%20%3D%209%29.%20Gene%20expression%20profiles%20from%20peripheral%20blood%20mononuclear%20cells%20%28PBMCs%29%20were%20analyzed%20across%20the%20first%20week%20after%20infusion.%20Paracrine%20mechanisms%20associated%20with%20these%20transcriptional%20changes%20were%20explored%20further%20by%20culturing%20patient%20PBMCs%20with%20MSC-conditioned%20medium%20%28MSC-CM%29%20or%20post-MSC%20infusion%20%28PI%29%20plasma%20to%20measure%20the%20regulatory%20effects%20of%20soluble%20factors%20that%20may%20be%20derived%20from%20MSCs.%20MSC-CM%20and%20PI-plasma%20were%20characterized%20further%20to%20identify%20potential%20immunoregulatory%20candidates.%20MSC%20infusion%20elicited%20a%20strong%20but%20transient%20transcriptional%20response%20in%20patient%20PBMCs%20that%20was%20sustained%20up%20to%207%20days.%20MSC%20infusion%20strongly%20downregulated%20transcriptional%20pathways%20related%20to%20interleukin%20%28IL%29-8%20and%20IL-1%5Cu03b2%2C%20which%20were%20also%20significantly%20inhibited%20in%20vitro%20following%20co-culture%20of%20PBMCs%20with%20MSC-CM%20and%20PI-plasma.%20MSC-derived%20soluble%20tumor%20necrosis%20factor%20receptor-1%2C%20transforming%20growth%20factor-%5Cu03b21%2C%20and%20extracellular%20vesicle-associated%20microRNAs%20were%20identified%20as%20potential%20mechanisms%20promoting%20these%20changes%2C%20but%20depletion%20of%20these%20individual%20candidates%20revealed%20inconsistent%20results.%20MSC-derived%20paracrine%20factors%20modulate%20important%20inflammatory%20pathways%20that%20are%20relevant%20to%20COPD%20pathogenesis.%20These%20data%20strengthen%20the%20hypothesis%20that%20therapies%20using%20MSCs%20and%20their%20secreted%20products%20may%20be%20beneficial%20to%20patients%20with%20COPD.%22%2C%22date%22%3A%22%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1002%5C%2Fsctm.21-0024%22%2C%22ISSN%22%3A%222157-6580%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fstemcellsjournals.onlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1002%5C%2Fsctm.21-0024%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-08-20T20%3A08%3A01Z%22%7D%7D%5D%7D
Armitage, J. D., Tan, D. B. A., Sturm, M., & Moodley, Y. P. (n.d.). Transcriptional profiling of circulating mononuclear cells from patients with chronic obstructive pulmonary disease receiving mesenchymal stromal cell infusions. STEM CELLS Translational Medicine, n/a(n/a). https://doi.org/10.1002/sctm.21-0024 Cite
